Facebook
Twitter
Telegram
Report an ErrorEyeGate Pharmaceuticals, Inc. Financial Statements 2011-2024 | EYEG
Annual Financial Statements EyeGate Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
28.9 M | 18.3 M | 17.4 M | 15.7 M | 15.8 M | 10.5 M | - | - | - | - |
Shares |
4.58 M | 3.18 M | 2.37 M | 951 K | 589 K | 411 K | - | - | - | - |
Net Income |
-8.09 M | -7.1 M | -10.8 M | -13.2 M | -13.3 M | -8.39 M | -1.77 M | -3.88 M | -6.03 M | - |
Revenue |
12.1 K | 2.69 M | 1.65 M | 408 K | 669 K | - | - | - | - | - |
EBITDA |
-8.18 M | -6.9 M | -10.8 M | -14.5 M | -13.3 M | -6.68 M | -2.46 M | -3.09 M | -5.83 M | - |
Operating Expenses |
8.22 M | 9.8 M | 12.5 M | 15 M | 14 M | 6.68 M | - | - | - | - |
General and Administrative Expenses |
4.66 M | 4.41 M | 4.44 M | 4.64 M | 5.59 M | 3.96 M | 1.93 M | 2.09 M | 2.82 M | - |
All numbers in USD currency